FDA Adverse Event Malfunction Summary report: N

I-STAT CREATININE CARTRIDGE

MDR report key: 20953800 · Received December 17, 2024

Report

Report Number
2245578-2024-00217
Event Type
Malfunction
Date Received
December 17, 2024
Date of Event
December 10, 2024
Report Date
January 15, 2025
Manufacturer
ABBOTT POINT OF CARE INC.
Product Code
CGL
PMA / PMN Number
K973292
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MT, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 09-JAN-2025. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS (FG) RELEASE CRITERIA. RETAINED AND RETURNED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA OUTLINED IN APPENDIX 1 OF Q04.01.003 REV. AN, PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN IDENTIFIED FOR CREA CARTRIDGE LOT A24301.

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4) APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 0

NA.

Description of Event or Problem · 0

ON 10-DEC-2024, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT CREA CARTRIDGES THAT YIELDED A SUSPECTED DISCREPANT CREATININE RESULTS ON A 48 YEAR OLD MALE SEEN FOR A CT EXAM. THERE WAS NO ADDITIONAL PATIENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. METHOD DATE COLLECTED TESTED RESULT-MG/DL SAMPLE I-STAT (B)(6) 2024 09:02 IMMEDIATELY 2.8 WB I-STAT (B)(6) 2024 09:11 IMMEDIATELY 2.5 WB I-STAT (B)(6) 2024 09:26 IMMEDIATELY 2.5 WB LAB (B)(6) 2024 09:38 NI 1.37 PLASMA THERE ARE NO INJURIES ASSOCIATED WITH THIS EVENT. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE INVESTIGATION IS UNDERWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1720126 I-STAT CREATININE CARTRIDGE CREA CARTRIDGE CGL ABBOTT POINT OF CARE INC. NA A24301

Patients

Seq Age Sex Outcome Treatment
1 48 YR Male